力诺药包
(301188)
| 流通市值：40.57亿 | | | 总市值：40.57亿 |
| 流通股本：2.39亿 | | | 总股本：2.39亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 721,014,626.29 | 498,727,431.13 | 275,983,006.27 | 1,080,841,711.81 |
| 营业收入 | 721,014,626.29 | 498,727,431.13 | 275,983,006.27 | 1,080,841,711.81 |
| 二、营业总成本 | 684,502,021.07 | 467,081,428.49 | 234,750,548.19 | 1,020,555,627.53 |
| 营业成本 | 568,340,738.68 | 391,534,631.89 | 202,931,144.74 | 875,376,509.53 |
| 税金及附加 | 5,006,057.35 | 3,325,889.53 | 1,655,458.21 | 7,082,780.76 |
| 销售费用 | 42,451,440.47 | 26,709,506.65 | 10,429,359.27 | 48,491,164.64 |
| 管理费用 | 28,022,618.53 | 18,749,429.77 | 6,787,649.47 | 38,538,881.61 |
| 研发费用 | 23,442,506.08 | 16,030,809.79 | 7,289,160.27 | 33,797,074.91 |
| 财务费用 | 17,238,659.96 | 10,731,160.86 | 5,657,776.23 | 17,269,216.08 |
| 其中:利息费用 | 19,196,541.06 | 13,151,383.79 | 6,827,524.6 | 25,775,480.43 |
| 其中:利息收入 | 2,794,658.46 | 1,870,930.46 | 926,202.04 | 6,811,743.57 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,410,220.4 | 1,105,578.17 | 522,506.7 | 1,454,305.47 |
| 加:投资收益 | 6,550,698.72 | 4,259,251.16 | 2,561,714.1 | 11,776,620.71 |
| 资产处置收益 | 2,380,717.62 | 2,380,717.62 | - | 20,945.09 |
| 资产减值损失(新) | -3,222,299.47 | -3,477,095.8 | -1,617,102.15 | -9,515,563.67 |
| 信用减值损失(新) | -1,188,106.92 | -1,055,724.74 | -2,373,380.88 | -1,551,653.69 |
| 其他收益 | 15,475,206.17 | 11,472,154.24 | 4,577,862.8 | 9,644,156.43 |
| 四、营业利润 | 57,919,041.74 | 46,330,883.29 | 44,904,058.65 | 72,114,894.62 |
| 加:营业外收入 | 613.79 | 9.18 | 76,530.01 | 20,251.73 |
| 减:营业外支出 | 36,038.47 | 6,037.5 | 1,294.5 | 686,218.33 |
| 五、利润总额 | 57,883,617.06 | 46,324,854.97 | 44,979,294.16 | 71,448,928.02 |
| 减:所得税费用 | 7,001,282.53 | 5,357,389.41 | 4,455,474.58 | 5,381,332.15 |
| 六、净利润 | 50,882,334.53 | 40,967,465.56 | 40,523,819.58 | 66,067,595.87 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 50,882,334.53 | 40,967,465.56 | 40,523,819.58 | 66,067,595.87 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 50,882,334.53 | 40,967,465.56 | 40,523,819.58 | 66,067,595.87 |
| 扣除非经常损益后的净利润 | 35,575,952.14 | 28,940,875.24 | 37,075,339 | 55,568,103.33 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.22 | 0.18 | 0.17 | 0.29 |
| (二)稀释每股收益 | 0.22 | 0.18 | 0.17 | 0.29 |
| 九、综合收益总额 | 50,882,334.53 | 40,967,465.56 | 40,523,819.58 | 66,067,595.87 |
| 归属于母公司股东的综合收益总额 | 50,882,334.53 | 40,967,465.56 | 40,523,819.58 | 66,067,595.87 |
| 公告日期 | 2025-10-28 | 2025-08-21 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |